Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

1 week ago 9
The acquisition brings a caller attack to treating allergic diseases to the company’s immunology pipeline.
Read Entire Article
  1. Homepage
  2. Technology
  3. Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

Related

Is MSG Maker Ajinomoto Sitting on an AI Goldmine? This Investor Thinks So

Is MSG Maker Ajinomoto Sitting on an AI Goldmine? This Inves...

3 hours ago 1
Florida AG Investigates OpenAI, ChatGPT, Citing National Security Risks, FSU Shooting

Florida AG Investigates OpenAI, ChatGPT, Citing National Sec...

12 hours ago 1
Opinion | New Data Centers Won’t Be Draining Us Dry

Opinion | New Data Centers Won’t Be Draining Us Dry

15 hours ago 1

Popular

50 Artists Travel Far and Wide to Learn From Filmmaker Werner Herzog

50 Artists Travel Far and Wide to Learn From Filmmaker Werne...

6 days ago 23
Plan to bring more beavers back takes step forward

Plan to bring more beavers back takes step forward

6 days ago 22
United to Offer No-Frills Fares in Its Premium Cabins

United to Offer No-Frills Fares in Its Premium Cabins

6 days ago 21
Would You Let AI Day Trade Your Money?

Would You Let AI Day Trade Your Money?

6 days ago 20
Big Banks Seeking a Piece of SpaceX’s I.P.O. Must Subscribe to Elon Musk’s Grok

Big Banks Seeking a Piece of SpaceX’s I.P.O. Must Subscribe ...

6 days ago 16
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved